Asia Pacific Medical Device and Diagnostics Contract Research Organization Market Size by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Asia Pacific Medical Device and Diagnostics Contract Research Organization Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Medical Devices, and Diagnostics) and Services (Clinical Data Management, Monitoring, Clinical Project Management, Medical Writing, Clinical Auditing, Digital Health, Clinical Strategy, and Others)

  • Report Date : Aug 2021
  • Report Code : TIPRE00024092
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 139

The medical device and diagnostics contract research organization market in APAC is expected to grow from US$ 2,394.72 million in 2021 to US$ 4,110.91 million by 2028; it is estimated to grow at a CAGR of 8.0% from 2021 to 2028.

Australia, China, India, Japan, and South Korea are major economies in APAC. Market consolidation on rise is the major factor driving the growth of the APAC medical device and diagnostics contract research organization market. The CRO services industry is highly fragmented, with several hundred small and medium-sized limited-service providers, and a small number of large and full-service CROs. There are a few barriers for smaller CROs to enter the APAC market. However, the full-service CROs require efficient infrastructure with an ability to simultaneously manage multiple complex testing services across numerous geographies, establish the requisite relationships with strategic partners, and develop relevant therapeutic and expertise to meet the needs of end users. Over the past a few years, the consolidation across the industry is an emerging trend followed by most of the prime players to strengthen their service offerings and garner the major market share in the APAC medical device & diagnostics contract research organization market. For instance, PAREXEL International Corp. acquired The Medical Affairs Company in 2017. This has led to the generation of larger CROs with the wide geographic diversification, extensive therapeutic and development expertise, enormous capital and technical resources to manage the demanding drug development programs, medical device designing and research as well as management of regulatory affairs for pharmaceutical and biopharmaceutical companies.     

Countries in APAC are facing an increasing incidence of COVID-19. Accompanying the catastrophic loss of life that the virus has caused is the impact on the global economy, which has reeled from the effects of the pandemic. The COVID-19 pandemic has critically impacted the region; however, it has also provided an opportunity for stakeholders to realign their future path based on strategic intent and focus. COVID-19 has created an extraordinary emergency that is particularly affecting the supply chain. The supply chain disruptions, along with the enormous need for medical devices and protective health care material, have generated the need for new initiatives and the use of emerging technologies such as three-dimensional printing (3DP) to come forward and support health care professionals and supply chain. The COVID-19 pandemic has adversely impacted the region, but it has also provided an opportunity for stakeholders to realign their future path based on strategic intent and focus. India and China are the most preferred destinations for outsourcing, where a large pool of skilled labor is available at a lower cost. With increasing pressure to reduce manufacturing costs and accelerate time-to-market, many devices and diagnostics companies are looking to conduct clinical trial operations in APAC. Increasingly, third-party outsourcing service providers are playing a greater role in supporting and managing the delivery of key business functions like medical device development, sales and marketing, and regulatory compliance services in APAC.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC medical device and diagnostics contract research organization market. The APAC medical device and diagnostics contract research organization market is expected to grow at a good CAGR during the forecast period.
APAC medical device and diagnostics contract research organization market

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

APAC Medical Device and Diagnostics Contract Research Organization Market Segmentation

APAC Medical Device and Diagnostics Contract Research Organization Market – By Type

  • Medical Devices
  • Diagnostics
    • Cardiac Biomarkers
    • Diabetes Management
    • Oncology
    • Infectious Diseases
    • Hematology
    • Chemistry and Immunoassays
    • Molecular Diagnostics
    • Others

APAC Medical Device and Diagnostics Contract Research Organization Market – By Services

  • Clinical Data Management
  • Monitoring
  • Clinical Project Management
  • Medical Writing
  • Clinical Auditing
  • Digital Health
  • Clinical Strategy
  • Others

APAC Medical Device and Diagnostics Contract Research Organization Market, by Country

  • Australia
  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC  

APAC Medical Device and Diagnostics Contract Research Organization Market - Companies Mentioned

  • Charles River Laboratories, Inc
  • ICON PLC
  • IQVIA
  • Laboratory Corporation of America Holdings
  • North American Science Associates, Inc.
  • PAREXEL International Corporation
  • Qserve Group B.V.
  • WUXI APPTEC

Asia Pacific Medical Device and Diagnostics Contract Research Organization Report Scope

Report Attribute Details
Market size in 2021 US$ 2,394.72 Million
Market Size by 2028 US$ 4,110.91 Million
Global CAGR (2021 - 2028) 8.0%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Type
  • Medical Devices
  • Diagnostics
By Services
  • Clinical Data Management
  • Monitoring
  • Clinical Project Management
  • Medical Writing
  • Clinical Auditing
  • Digital Health
  • Clinical Strategy
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Charles River Laboratories, Inc
  • ICON PLC
  • IQVIA
  • Laboratory Corporation of America Holdings
  • North American Science Associates, Inc.
  • PAREXEL International Corporation
  • Qserve Group B.V.
  • WUXI APPTEC
  • Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    1. Charles River Laboratories, Inc
    2. ICON PLC
    3. IQVIA
    4. Laboratory Corporation of America Holdings
    5. North American Science Associates, Inc.
    6. PAREXEL International Corporation
    7. Qserve Group B.V.
    8. WUXI APPTEC
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo